These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 22940680)

  • 1. Variant on chromosome 9p is associated with left ventricular mass: results from two cohorts of essential hypertensive individuals.
    Menni C; Boffi L; Cesana F; Viviani Anselmi C; Nava S; Bertola F; Blasio AM; Roncarati R; Trimarco V; Marino M; Trimarco B; Grassi G; Giannattasio C; Mancia G
    J Hypertens; 2012 Nov; 30(11):2144-50. PubMed ID: 22940680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never-treated hypertensive patients. Suggestive evidence for a digenic additive modulation.
    Perticone F; Maio R; Di Paola R; Sciacqua A; Marucci A; De Cosmo S; Perticone M; Sesti G; Trischitta V
    Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):181-7. PubMed ID: 17367703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women.
    Peter I; Shearman AM; Vasan RS; Zucker DR; Schmid CH; Demissie S; Cupples LA; Kuvin JT; Karas RH; Mendelsohn ME; Housman DE; Benjamin EJ
    Am J Hypertens; 2005 Nov; 18(11):1388-95. PubMed ID: 16280269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of the CYP3A5*1 allele with blood pressure and left ventricular mass and geometry: the KORA/MONICA Augsburg echocardiographic substudy.
    Lieb W; Bolbrinker J; Döring A; Hense HW; Erdmann J; Schunkert H; Kreutz R
    Clin Sci (Lond); 2006 Dec; 111(6):365-72. PubMed ID: 16822233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S; Sciarretta S; Ciavarella GM; Venturelli V; De Paolis P; Tocci G; De Biase L; Ferrucci A; Volpe M
    J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study.
    de Simone G; Kitzman DW; Palmieri V; Liu JE; Oberman A; Hopkins PN; Bella JN; Rao DC; Arnett DK; Devereux RB
    Am J Hypertens; 2004 Sep; 17(9):828-33. PubMed ID: 15363827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
    Cuspidi C; Giudici V; Negri F; Meani S; Sala C; Zanchetti A; Mancia G
    J Hypertens; 2009 Dec; 27(12):2465-71. PubMed ID: 19898252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
    J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.
    Wahlstrand B; Orho-Melander M; Delling L; Kjeldsen S; Narkiewicz K; Almgren P; Hedner T; Melander O
    J Hypertens; 2009 Apr; 27(4):769-73. PubMed ID: 19293724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Adrenergic receptor gene polymorphism is a genetic risk factor for cardiovascular disease: a cohort study with hypertensive patients.
    Iwamoto Y; Ohishi M; Yuan M; Tatara Y; Kato N; Takeya Y; Onishi M; Maekawa Y; Kamide K; Rakugi H
    Hypertens Res; 2011 May; 34(5):573-7. PubMed ID: 21289629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene.
    Ott C; Titze SI; Schwarz TK; Kreutz R; Hilgers KF; Schmidt BM; Schlaich MP; Schmieder RE
    J Hypertens; 2007 Aug; 25(8):1627-32. PubMed ID: 17620959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects.
    Mulè G; Nardi E; Cottone S; Cusimano P; Incalcaterra F; Giandalia ME; Palermo A; Mezzatesta G; Cerasola G
    Int J Cardiol; 2007 Oct; 121(3):267-75. PubMed ID: 17258825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients.
    Huber M; Völler H; Jakob S; Reibis R; Do V; Bolbrinker J; Zergibel I; Schmieder RE; Treszl A; Wegscheider K; Kreutz R
    J Hypertens; 2010 Jun; 28(6):1221-9. PubMed ID: 20467270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension.
    Ratto E; Leoncini G; Viazzi F; Bezante GP; Falqui V; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Feb; 26(2):345-50. PubMed ID: 18192849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of beta 1-adrenergic receptor gene polymorphisms with left ventricular hypertrophy in human essential hypertension.
    Fu C; Wang H; Wang S; Shi Y; Zhou X; Sun K; Chen J; Song X; Xue H; Hui R
    Clin Biochem; 2008 Jul; 41(10-11):773-8. PubMed ID: 18298953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
    Talmud PJ; Flavell DM; Alfakih K; Cooper JA; Balmforth AJ; Sivananthan M; Montgomery HE; Hall AS; Humphries SE
    Clin Sci (Lond); 2007 Jun; 112(12):617-24. PubMed ID: 17291198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variation at the 11-β hydroxysteroid dehydrogenase type 1 gene is associated with left ventricular mass.
    Rahman TJ; Mayosi BM; Hall D; Avery PJ; Stewart PM; Connell JM; Watkins H; Keavney B
    Circ Cardiovasc Genet; 2011 Apr; 4(2):156-62. PubMed ID: 21402901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.